THEY SAID IT! SENATORS HIGHLIGHT URGENCY TO HOLD BIG PHARMA ACCOUNTABLE TO LOWER DRUG PRICES
Feb 13, 2023
Senate Judiciary Committee Advances Bipartisan Legislation Cracking Down on… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA EARNINGS WATCH: PFIZER, AMGEN, GLAXOSMITHKLINE, NOVARTIS AND JOHNSON & JOHNSON
Feb 6, 2023
Brand Name Drug Companies Kick Off Q4 Earnings Calls After More than 600 Price… Read More
DOSE OF REALITY: SENATE HEARING PROVIDES OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS PATENT ABUSE
Feb 2, 2023
Critical Legislation Targets Anti-Competitive Practices like Patent Thickets… Read More
DOSE OF REALITY: BIG PHARMA’S PATENT THICKETS COST PATIENTS AND TAXPAYERS BILLIONS IN LOST SAVINGS EACH YEAR
Jan 26, 2023
New Matrix Global Advisors Report Shines Light on Cost of Big Pharma’s… Read More
BIG PHARMA WATCH: BIG PHARMA SET RECORD FOR OUT-OF-CONTROL LAUNCH PRICES IN 2022 AS MEDIAN PRICE OF NEW TREATMENTS SURGED PAST $220,000
Jan 6, 2023
Brand Name Drug Companies Setting Egregious Prices on New Products Not… Read More
BIG PHARMA WATCH: U.S. HOUSE REPORT DETAILS “UNJUSTIFIABLY HIGH PRICE” OF UNPROVEN ALZHEIMER’S DRUG ADUHELM
Jan 3, 2023
Congressional Probe Concludes Biogen Set Egregious Price Tag on Aduhelm to… Read More
DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2022
Dec 28, 2022
Get the Facts on Big Pharma’s Year of Out-of-Control Launch Prices… Read More
TWO BIRDS OF A FEATHER: BIG PHARMA PRICE HIKERS TO JOIN FORCES IN LARGEST HEALTH CARE MERGER OF THE YEAR
Dec 13, 2022
Amgen and Horizon Therapeutics Eye Merger As Both Continue to Hike Prices on… Read More
SECOND OPINION: BIG PHARMA EXEC BOOED AS HE DISMISSES AFFORDABILITY CONCERNS ON HIGH PRICED TREATMENTS AS “LUDICROUS”
Dec 9, 2022
Regeneron Co-Founder Says, “Forget About That” When Pressed on How… Read More
BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST SEVEN DRUGS COST U.S. $805 MILLION IN 2021
Dec 7, 2022
Brand Name Drug Companies Continue Raising Prices on Blockbuster Products With… Read More
BIG PHARMA WATCH: MERCK PLOTS TO FURTHER BLOCK COMPETITION AND EXTEND MONOPOLY PRICING ON BLOCKBUSTER CANCER DRUG KEYTRUDA
Dec 2, 2022
Big Pharma Giant Wants New Patents for Formulation Changes That Won’t… Read More
BIG PHARMA WATCH: DRUG COMPANY VERTEX PRICE-GOUGING BRAND NAME CYSTIC FIBROSIS TREATMENTS AND BANKING HUGE PROFITS
Nov 30, 2022
Patient Advocates Warn Access to Egregiously Priced Treatments at Risk Drug… Read More